We are the Faculty of Medicine & Dentistry at the University of Alberta, one of the world’s elite academic health sciences centres, where top students are taught by award-winning educators and mentored by renowned scientists in a dynamic learning environment.
We conduct our teaching, research and patient care in accordance with the highest international standards. We work with our partners in education, research and health care for the greater good of the local, regional and global community.
Outstanding areas of medical research at the University of Alberta include diabetes, obesity, virology, heart disease, motor control and rehabilitation, protein structure and function, and transplantation.
July 14, 2017
Suppressed oligodendrocyte steroidogenesis in multiple sclerosis: Implications for regulation of neuroinflammation (Boghozian et al.)
October 12, 2016
Insulin Treatment Prevents Neuroinflammation and Neuronal Injury with Restored Neurobehavioral Function in Models of HIV/AIDS Neurodegeneration. (Mamik et al.)
April 4, 2019
A virus, previously thought to present little harm, has just been shown to be among the variety of causes of encephalitis. Researchers are now working on treatment for pegivirus
February 21, 2019
Discovery of viral culprit may open new areas of research to develop potential therapies.
September 24, 2018
Human pegivirus-1 associated leukoencephalitis: Clinical and molecular features (Balcom et al.)
June 26, 2018
Caspase-1 inhibition prevents glial inflammasome activation and pyroptosis in models of multiple sclerosis (McKenzie et al.)
June 12, 2018
Researchers discover role of programmed cell death, previously only associated with inflammation, in multiple sclerosis.
May 3, 2018
A symposium on multiple sclerosis in Edmonton will focus on the link between the human gut, the brain and the disease.
September 20, 2011
Media Event: Jeff Junod, Multiple Sclerosis Patients, and Chris Power (Video)
October 21, 2010
Alberta neurologist's findings published in prestigious international journal (Video)